Showing results 17 to 22 of 22
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Repurposing hyperpolarization‐activated cyclic nucleotide‐gated channels as a novel therapy for breast cancer Journal:Clinical and Translational Medicine | 2021 | ||
2016 | |||
Targeting androgen receptor in BQ323636.1 overexpressing ER+ breast cancer to overcome aromatase inhibitor resistance Proceeding/Conference:The Virtual New Zealand Breast Cancer Symposium, 2021 | 2021 | ||
Targeting CHK2 to reverse tamoxifen resistance by reducing BQ323636.1 in ER-positive breast cancer Proceeding/Conference:The Virtual New Zealand Breast Cancer Symposium, 2021 | 2021 | ||
2022 | |||
Translational regulation by eIF4E and its contribution to tamoxifen resistance in breast cancer Proceeding/Conference:Cancer Research | 2016 |